* Says U.S. FDA approved nucleus implants for magnetic resonance imaging use up to 3.0T with magnet removed 登録するここ. * Additionally, with use of cochlear nucleus implant bandage and splint kit, nucleus ...

Cochlear Limited, the global leader in implantable hearing solutions, announced the US Food and Drug Administration (FDA) approval of the Cochlear Nucleus Nexa System – the world’s first and only, ...

Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

[画像1: https://prtimes.jp/i/79047/42/resize/d79047-42-277c0f5ae9068047b46e-0.jpg] 人工内⽿システムのパイオニア・豪コクレア社の日本法人 ...

Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® ...

LONE TREE, Colo., Feb. 25, 2025 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is thrilled to announce the winners of 2025 annual Cochlear Academic ...

The near-$18bn group is now guiding to an underlying net profit of between $390m and $400m, comparing to its FY24 result of $386.6m. At the time of its first-half results release in February, Cochlear ...

Investing.com - Canaccord Genuity upgraded Cochlear Ltd. (ASX:COH) from Hold to Buy and set a price target of AUD330.00, citing strong device demand and promising technology developments. The hearing ...